Medical Condition News

RSS

Livongo Health, Iron Mountain collaborate to improve health of their employees with diabetes

Livongo Health, a consumer digital health company that is focused on using technology to empower people with chronic conditions to live better, today announced an agreement with Iron Mountain Incorporated. They wanted to improve the health and productivity of their employees with diabetes while reducing the cost of care.

14 Dec 2014

ALS Association announces research funds to further understand genetic cause of ALS

The ALS Association is pleased to announce the award of $326,662 in research funds to expand ongoing natural history studies in order to further understand the most common genetic cause of ALS, in preparation for clinical trials in those whose disease is affected by this gene.

14 Dec 2014

St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of the Quadra Allure MP™ cardiac resynchronization therapy pacemaker (CRT-P).

13 Dec 2014

UR researchers on track to solve mystery of weight gain

University of Rochester researchers believe they're on track to solve the mystery of weight gain - and it has nothing to do with indulging in holiday eggnog.

12 Dec 2014

MD Anderson president applauds FDA's approval of new vaccine for HPV-related cancers

The Food and Drug Administration's approval of a new vaccine that targets five additional strains of human papilloma virus (HPV) fortifies a proven cancer-prevention weapon, according to Ronald A. DePinho, M.D., president of The University of Texas MD Anderson Cancer Center.

12 Dec 2014

Study suggests that hospitals perform more partial nephrectomies after acquiring robots

Hospitals with robotic surgical systems are more likely to perform "nephron-sparing" partial nephrectomy--a recommended alternative to removal of the entire kidney--in patients with kidney cancer, reports a study in the December issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

12 Dec 2014

MU researcher recognized as AAAS Fellow for contributions to ophthalmology research

Cataracts, a clouding of the lens in the eye leading to vision loss, affects more than 24 million people in the United States, according to National Institutes of Health estimates. Often linked to the natural process of aging, cataracts are a major cause of blindness worldwide. K. Krishna Sharma, an ophthalmology researcher at the University of Missouri, has worked for more than two decades to study the mechanisms involved in this degenerative disease.

12 Dec 2014

Patients with Parkinson's disease have different microbiota in their intestines

Parkinson's disease sufferers have a different microbiota in their intestines than their healthy counterparts, according to a study conducted at the University of Helsinki and the Helsinki University Central Hospital. Researchers are now trying to determine what the connection between intestinal microbes and Parkinson's disease is.

12 Dec 2014

Study finds link between hypoglycaemia and increased risk of cardiovascular events

A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes.

12 Dec 2014

New statistical model enables better identification of different cell types in solid tumors

A new statistical model developed by a research team at Worcester Polytechnic Institute may enable physicians to create personalized cancer treatments for patients based on the specific genetic mutations found in their tumors.

12 Dec 2014

UB study creates new awareness for diabetics who are at risk for dehydration

Some drugs used to treat diabetes mimic the behavior of a hormone that a University at Buffalo psychologist has learned controls fluid intake in subjects. The finding creates new awareness for diabetics who, by the nature of their disease, are already at risk for dehydration.

12 Dec 2014

Research finding could lead to new therapies for malignant glioma

Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.

12 Dec 2014

New interoperability standards for diabetes devices

JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.

12 Dec 2014

Cold 'sensor' hold key to new therapeutic target for treatment of frostbite and hypothermia

A cold 'sensor' which triggers the skin's vascular response to the cold could represent an exciting new therapeutic target for the treatment of frostbite and hypothermia, according to scientists at King's College London.

12 Dec 2014

New Cancer Council data finds fivefold increase in thyroid cancer rates

New Cancer Council data has found a fivefold increase in rates of thyroid during the past 30 years in Queensland, with nearly 500 Queenslanders diagnosed in 2012 compared to less than 50 diagnoses in 1982.

12 Dec 2014

IRCM researchers uncover mechanism that regulates dopamine levels in the brain

Researchers in Montréal led by Jacques Drouin, D.Sc., uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson's disease.

12 Dec 2014

MSU researchers find possible way to boost healthy cell production in cancer patients during chemo

Michigan State University scientists are closer to discovering a possible way to boost healthy cell production in cancer patients as they receive chemotherapy. By adding thymine - a natural building block found in DNA - into normal cells, they found it stimulated gene production and caused them to multiply.

12 Dec 2014

Medical Condition News

Livongo Health, Iron Mountain collaborate to improve health of their employees with diabetes

ALS Association announces research funds to further understand genetic cause of ALS

St. Jude Medical receives CE Mark approval for Quadra Allure MP CRT-P

UR researchers on track to solve mystery of weight gain

MD Anderson president applauds FDA's approval of new vaccine for HPV-related cancers

Study suggests that hospitals perform more partial nephrectomies after acquiring robots

MU researcher recognized as AAAS Fellow for contributions to ophthalmology research

Patients with Parkinson's disease have different microbiota in their intestines

Study finds link between hypoglycaemia and increased risk of cardiovascular events

New statistical model enables better identification of different cell types in solid tumors

UB study creates new awareness for diabetics who are at risk for dehydration

Research finding could lead to new therapies for malignant glioma

New interoperability standards for diabetes devices

Cold 'sensor' hold key to new therapeutic target for treatment of frostbite and hypothermia

New Cancer Council data finds fivefold increase in thyroid cancer rates

IRCM researchers uncover mechanism that regulates dopamine levels in the brain

MSU researchers find possible way to boost healthy cell production in cancer patients during chemo

Scientific collaboration reveals encouraging insight on AMD disease

Scientists to explore biology of human asthma by using slime mould

CWRU researchers find mechanism that enables LRAT enzyme to store vitamin A

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News